Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01866319
Brief Title: Study to Evaluate the Safety and Efficacy of Two Different Dosing Schedules of Pembrolizumab (MK-3475) Compared to Ipilimumab in Participants With Advanced Melanoma (MK-3475-006/KEYNOTE-006)

First Submitted : May 28, 2013
First Submitted that Met QC Criteria : May 28, 2013
First Posted : May 31, 2013 (Estimate)

Results First Submitted : December 9, 2015
Results First Submitted that Met QC Criteria : December 9, 2015
Results First Posted : January 14, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : May 22, 2020
Last Update Posted : June 2, 2020